Subtotal gastrectomy combined with chemotherapy: An effective therapy for patients with circumscribed Borrmann type IV gastric cancer

Huang, Hongyun; Gao, Zhiqiang; Sun, An-Qi; Liang, W M; Li, Kai

doi:10.4251/wjgo.v12.i11.1325

Cited by 3 publications

(2 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The present study indicated that the clinical outcome of RAPC in patients with different Borrmann types was significantly different. Huang et al found that lymph-node metastasis was an independent risk factor limiting the prognosis of patients with Borrmann IV disease (7). In the present study, the median survival of patients with Borrmann type IV gastric cancer without lymph-node metastasis was 27 months compared to 12 months for their counterparts with lymph-node metastasis.…”

Section: Discussioncontrasting

confidence: 44%

Survival Response of Patients With Gastric Cancer Treated With Regional Arterial-Perfusion Chemotherapy Is Correlated With Borrmann Classification

Liang

Liu

et al. 2021

Anticancer Res

View full text Add to dashboard Cite

Section: Discussioncontrasting

confidence: 44%

Survival Response of Patients With Gastric Cancer Treated With Regional Arterial-Perfusion Chemotherapy Is Correlated With Borrmann Classification

Liang

Liu

et al. 2021

Anticancer Res

View full text Add to dashboard Cite

“…Previous research showed that Borrmann type IV was related to worse survival ( 26 – 28 ). Our study revealed that Borrmann type IV was more prevalent in females, which was discovered to be a risk factor for fatal 5-year OS outcomes in the PAS group.…”

Section: Discussionmentioning

confidence: 99%

Gastric cancer clinical characteristics and their altered trends in South China: An epidemiological study with 2,800 cases spanning 26 years

Wei

Zhan²,

Liao³

et al. 2023

Front. Oncol.

View full text Add to dashboard Cite

BackgroundGastric cancer (GC) is a serious threat to human health. The clinical GC characteristics in China may be impacted by changes in people’s lifestyles and the promotion of early GC (EGC) screening. The present study aims to evaluate the recent trends of GC characteristics in South China and search for hazardous factors limiting the survival time of GC patients.MethodsData on GC patients that were hospitalized in the Department of Digestive Center, the First Affiliated Hospital, Sun Yat-sen University, from 1994 to 2019 were collected and divided into two categories according to the time when the EGC screening began in China: the PRE group (previous 13 years, 1994–2006) and the PAS group (past 13 years, 2007–2019).ResultsWe found that, although the 5-year survival rate increased in the PAS group compared with the PRE group (P < 0.0001), patients with age ≥60 years or Borrmann type IV still had a worse prognosis. In the PAS group, the larger percentages of elderly patients and patients with Borrmann type IV in the lymphatic metastases (N1) group (41.0% vs. 51.1%, P = 0.0014) and stage IV subgroup (20.7% vs. 32.2%, P = 0.016), respectively, when compared with the PRE group, may have contributed to the poor outcome of GC. By comparing the odds ratio (OR) of 5-year overall survival (OS) in the two 13-year periods, female sex and T2 turned into risk factors because of a greater proportion of Borrmann type IV or elderly patients in the PAS group (OR = 0.983, 95% CI = 0.723–1.336 vs. OR = 1.277, 95% CI = 1.028–1.586 and OR = 1.545, 95% CI = 0.499–4.775 vs. OR = 2.227, 95% CI = 1.124–4.271, respectively).ConclusionsDespite the GC epidemiology changes, the overall prognosis of GC patients has improved in South China. However, old age and Borrmann type IV are still the major restrictions affecting the survival of GC patients, a situation which calls for additional attention.

show abstract

Effectiveness of the CANCER-AIMS intervention on nutritional status and symptom management in patients with gastric cancer following gastrectomy: A randomized controlled trial

Ren,

Fu,

Wang

et al. 2024

International Journal of Nursing Studies

View full text Add to dashboard Cite

Subtotal gastrectomy combined with chemotherapy: An effective therapy for patients with circumscribed Borrmann type IV gastric cancer

Cited by 3 publications

References 23 publications

Survival Response of Patients With Gastric Cancer Treated With Regional Arterial-Perfusion Chemotherapy Is Correlated With Borrmann Classification

Survival Response of Patients With Gastric Cancer Treated With Regional Arterial-Perfusion Chemotherapy Is Correlated With Borrmann Classification

Gastric cancer clinical characteristics and their altered trends in South China: An epidemiological study with 2,800 cases spanning 26 years

Effectiveness of the CANCER-AIMS intervention on nutritional status and symptom management in patients with gastric cancer following gastrectomy: A randomized controlled trial

Contact Info

Product

Resources

About